HEcoPerMed

The special issue dedicated to the HEcoPerMed project is available online in the Journal of Personalized Medicine. @iMTAnews @DLR_en @HERC_Oxford @ICPerMed @futuresciencegp @fsgpme #healtheconomics #personalisedmedicine

@iMTAnews @DLR_en @HERC_Oxford @ICPerMed @EPPerMed @futuresciencegp @fsgpme 5/5 the third most read article is the cost-effectiveness study of extended DPYD testing prior to fluoropyrimidine chemotherapy in metastatic breast cancer futuremedicine.com/doi/10.2217/pm…

@iMTAnews @DLR_en @HERC_Oxford @ICPerMed @EPPerMed @futuresciencegp @fsgpme 4/5 the most read Editorial is the introduction to the HecoPerMed Special Focus Issue futuremedicine.com/doi/10.2217/pm…

According to the foreword published in the Journal of Personalized Medicine, "Looking back over 2023 and welcome to the 21st issue of Personalized Medicine", @hecopermed Special Focus Issue has generated a lot of interest with papers featured in the most read and cited articles🧵

Access the special issue here -> futuremedicine.com/toc/pme/20/4

@ICPerMed: Researchers from the HEcoPerMed consortium published a special issue of Future Medicine / Personalised Medicine @iMTAnews @DLR_en @HERC_Oxford @futuresciencegp @fsgpme #healtheconomics #personalisedmedicine icpermed.eu/en/1161.php

We would like to thank all experts in the field of personalised medicine who attended our workshops and conference, and supported us.

The special issue dedicated to the HEcoPerMed project is available online in the Journal of Personalized Medicine. @iMTAnews @DLR_en @HERC_Oxford @ICPerMed @futuresciencegp @fsgpme #healtheconomics #personalisedmedicine

#ISPOREurope Vienna Workshop "Is There Large Underused Potential in Using Genetic Tests to Better Stratify Patients to Established Therapies?”. Monday 7 Nov, 16.30-17.30. @iMTAnews @HERC_Oxford #SyreonResearchInstitute

HEcoPerMed team is going to #ISPOREurope in Vienna to present "Is There Large Underused Potential in Using Genetic Tests to Better Stratify Patients to Established Therapies?”. Join our workshop on Monday 7 Nov, 16.30-17.30. @iMTAnews @HERC_Oxford @ICPerMed

NEW PUBLICATION Cost-Effectiveness Analysis of Treating Patients With NTRK-Positive Cancer With the Histology-Independent Therapy Entrectinib @iMTAnews #SyreonResearchInstitute @HERC_Oxford @ICPerMed #healtheconomics sciencedirect.com/science/articl…